You are viewing the site in preview mode

Skip to main content

Table 4 Univariate analysis of factors associated with overall survival

From: Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer

Variables Univariate analysis
HR 95% CI P
Age (< 65 vs. ≥65) 1.47 0.68–3.17 NS
Gender (female vs. male) 0.74 0.29–1.84 NS
Stage (I vs. II vs. III) 1.64 1.00–2.69 0.049
Histology (adeno vs. other) 1.50 0.69–3.27 NS
Lymph node status (negative vs. positive) 2.09 0.95–4.60 NS
pT status (pT1a-2b vs. pT3–4) 2.65 1.25–5.62 0.011
Differentiation (poor vs. well-moderate) 0.80 0.37–1.75 NS
Smoking (smokers vs. nonsmokers) 0.48 0.18–1.23 NS
COPD (present vs. absent) 1.17 0.54–2.55 NS
M1 macrophages in islets (high vs. low) 2.83 1.20–6.68 0.017
M1 macrophages in stroma (high vs. low) 1.91 0.86–4.25 NS
Total M1 macrophages (high vs. low) 1.43 0.63–3.21 NS
M2 macrophages in islets (high vs. low) 1.43 0.66–1.43 NS
M2 macrophages in stroma (high vs. low) 1.00 0.73–1.37 NS
Total M2 macrophages (high vs. low) 0.31 0.13–0.75 0.009
IL-10 0.74 0.35–1.55 NS
TNF-α 1.16 0.55–2.45 NS
IFN-γ 0.67 0.31–1.43 NS
  1. HR hazard ratio, CI confidence interval, NS not significant